New cementum formation induced by cyclosporin A: a histological, ultrastructural and histomorphometric study in the rat.
Cyclosporin A (CsA), a widely used immunosuppressive agent, is known to induce gingival overgrowth; 30 mg/kg/d of CsA were administrated orally in young and adult male Sprague-Dawley rats. The same number of rats received oil-based vehicle solution. After 4, 9, 14 and 19 wk of CsA or vehicle administration 3 control and 3 experimental rats were anaesthetized and tissues fixed by an intracardiac perfusion of fixative solution. Upper and lower jaws were dissected, demineralized and processed for Epon inclusion. Histological examination revealed the presence of large amounts of new cementum (NC) covering extensive areas of the acellular extrinsic fibre cementum (AEFC) in all the root surfaces. NC was particularly abundant at the cervical third of the roots facing the gingival connective tissue, where it occurred as layers, spurs or in both configurations. NC was characterized by its irregular outline, globular body content and infrequent presence of incremental lines. Histomorphometric evaluation by semi-automatic image analysis indicated that the volume and the external surface of NC spurs were 2.86-6.49 and 1.29-1.97-fold increased comparative to those of the AEFC covering the same root areas. Electron microscopy revealed that NC was a functional tissue with insertion of collagen fibres perpendicularly to the long axis of the root. It can be concluded that under some experimental conditions formation of abundant amounts of NC can be achieved and that these results must be taken into account for a new approach in the treatment of periodontal disease.
Ayanoglou
C M
CM
Laboratoire Biologie et Biomatériaux du Milieu Buccal et Osseux (Groupe Matrices Extracellulaires et Biominéralisations), Faculté de Chirurgie Dentaire, Université Paris V, Montrouge, France.
Lesty
C
C
D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D003094:Collagen / Q000648:ultrastructure; D003238:Connective Tissue / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D003648:Decalcification Technique; D003739:Dental Cementum / Q000187:drug effects* / Q000473:pathology / Q000648:ultrastructure; D005404:Fixatives; D005500:Follow-Up Studies; D005881:Gingiva / Q000473:pathology; D019214:Gingival Overgrowth / Q000139:chemically induced; D007091:Image Processing, Computer-Assisted; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008854:Microscopy, Electron; D009805:Odontogenesis / Q000187:drug effects*; D010510:Periodontal Diseases / Q000628:therapy; D014677:Pharmaceutical Vehicles; D010919:Placebos; D016613:Plastic Embedding; D051381:Rats; D017207:Rats, Sprague-Dawley; D016707:Tissue Fixation; D019227:Tooth Apex / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D019237:Tooth Cervix / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure; D014092:Tooth Root / Q000187:drug effects / Q000473:pathology / Q000648:ultrastructure
D005404:Fixatives; D007166:Immunosuppressive Agents; D014677:Pharmaceutical Vehicles; D010919:Placebos; D016572:Cyclosporine; D003094:Collagen